Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Louis Riley who wrote (3757)	12/16/1997 3:01:00 PM
From: Anaxagoras	Read Replies (1) \| Respond to of 23519

Yeah, I posted that eariler this morning. Someone already pointed out it's old news mentioned on the CC. Apparently, VVUS claims IMRI sales make up very little of their revenue. Anaxagoras

To: Louis Riley who wrote (3757)	12/16/1997 4:10:00 PM
From: mc	Respond to of 23519

Even if some treatment centers close, I don't know how this would produce a decline in demand for MUSE. If you were impotent and found a solution to your problem would you stop using the drug because your doctor's office closed? Of course not. It might eliminate one small channel of future demand growth, but, once the PR campaign rolls out in February, 5 treatment facilities will be very small potatoes (they are now for that matter). Gary "Long and really bitter about margin calls" McBride